Descriptive epidemiology of gastric adenocarcinoma in the State of Texas by ethnicity: Hispanic versus White non-Hispanic

Corral, Javier; Hakim, Nawar; Mulla, Zuber D.

doi:10.1007/s10120-011-0127-0

Cited by 12 publications

(22 citation statements)

References 41 publications

(38 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies with data from U.S. hospitals and SEER reviews show that in general, Hispanics have more distal type cancer than non-Hispanic Whites [14,15,18]. In addition, most distal incident cases were found in the antrum in Central America, whereas cancer of the corpus was slightly more frequent among U.S. Hispanics.…”

Section: Discussionmentioning

confidence: 99%

“…Gastric cancer incidence rates for Hispanics in the U.S. are nearly double those of whites [13]. In addition, Hispanics have more distal type cancer than non-Hispanic Whites [14,15]. Interestingly, recent studies suggest an increase in diffuse cancer in foreign born Hispanic men and U.S. born Hispanic women [16].…”

Section: Introductionmentioning

confidence: 99%

“…Interestingly, recent studies suggest an increase in diffuse cancer in foreign born Hispanic men and U.S. born Hispanic women [16]. Hispanic ethnicity has also been associated with diagnosis at a younger age, less differentiated tumors, and different metastasis pattern (more peritoneal and less hepatic metastases) [15,14]. …”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

The Descriptive Epidemiology of Gastric Cancer in Central America and Comparison with United States Hispanic Populations

Corral

Hurtado

Domínguez³

et al. 2014

J Gastrointest Canc

View full text Add to dashboard Cite

Purpose Delineate the epidemiology of gastric adenocarcinoma in Central America and contrast it with Hispanic-Latino populations in the U.S. Methods Published literature and Central America Ministry of Health databases were used as primary data sources, including national, population-based and hospital-based registries. U.S. data was obtained from the NCI-SEER registry. Incident gastric adenocarcinoma cases were analyzed for available data between 1985–2011, including demographic variables and pathology information. Results In Central America, 19,741 incident gastric adenocarcinomas were identified. Two-thirds of cases were male, 20.5% were under age 55, and 58.5% were from rural areas. In the SEER database (n=7,871), 57.8% were male, and 28.9% were under age 55. Among the U.S. Hispanics born in Central America with gastric cancer (n=1,210), 50.3% of cases were male, and 38.1% were under age 55. Noncardia gastric cancer was more common in Central America (83.3%), among U.S. Hispanics (80.2%), and Hispanics born in Central America (86.3%). Cancers of the antrum were more common in Central America (73.6%), whereas cancers of the corpus were slightly more common among U.S. Hispanics (54.0%). Adenocarcinoma of the diffuse subtype was relatively common, both in Central America (35.7%), and U.S. Hispanics (69.5%), although Lauren classification was reported in only 50% of cases. Conclusions A significant burden of gastric adenocarcinoma is observed in Central America based upon limited available data. Differences are noted between Central America and U.S. Hispanics. Strengthening population-based registries is needed for improved cancer control in Central America, which may have implications for the growing U.S. Hispanic population.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Descriptive Epidemiology of Gastric Cancer in Central America and Comparison with United States Hispanic Populations

Corral

Hurtado

Domínguez³

et al. 2014

J Gastrointest Canc

View full text Add to dashboard Cite

show abstract

“…Recent data from the Surveillance Epidemiology and End Results (SEER) Program showed that the gastric cancer incidence rate for Hispanics in the United States is double that of Caucasians and gastric cancer is the seventh leading cause of cancer death in this population. Hispanic patients with gastric cancer tend to present with more advanced disease, diffuse‐type and signet ring cell histology, and linitis plastica relative to Caucasian patients …”

Section: Introductionmentioning

confidence: 99%

“…Hispanic patients with gastric cancer tend to present with more advanced disease, diffuse-type and signet ring cell histology, and linitis plastica relative to Caucasian patients. 3,9 In addition to having a distinct clinical profile, Hispanic patients with gastric cancer face unique challenges in access to care. This is particularly true for undocumented immigrants who cannot afford or are not eligible for insurance.…”

mentioning

confidence: 99%

Evaluation of treatment and outcomes for Hispanic patients with gastric cancer at Commission on Cancer‐accredited centers in the United States

Zhao

Leichman

Horgan

et al. 2019

Journal of Surgical Oncology

View full text Add to dashboard Cite

Background and Objectives Gastric cancer in the Hispanic population commonly presents with poor clinical features. Characteristics of this vulnerable population and optimal therapy for these patients have not been clearly defined. Methods Using the National Cancer Database (2004‐2014), we analyzed patient demographics, clinical factors, treatment‐related factors, and outcomes for Hispanic and non‐Hispanic patients with gastric adenocarcinoma in the United States. Results A total of 129 666 patients were included in this analysis. Hispanics were younger, more often female, had larger tumors, and were more likely to present with metastatic disease (all P < 0.001). Hispanics were more likely to undergo staging laparoscopy (5.6% vs 4.9%; P = 0.037), gastrectomy (63.5% vs 56.9%; P < 0.001), and ≥ 15 lymph nodes examined (56.1% vs 50.5%; P < 0.001). Hispanics were less likely to have negative margins (91.2% vs 92.8%; P = 0.004). Hispanics with stage II/III disease were less likely to receive neoadjuvant therapy (31.7% vs 38.7%; P < 0.001), but more likely to receive multimodal therapy (48.9% vs 46.1%; P = 0.01). Predictors for improved overall survival in Hispanics included multimodal therapy, negative margins, and treatment at an academic center. Conclusions Efforts to optimize treatment of this distinct and growing population of gastric cancer patients should focus on earlier diagnosis, referral to academic centers, and high‐quality surgery.

show abstract

Gastric adenocarcinoma burden and late‐stage diagnosis in Latino and non‐Latino populations in the United States and Texas, during 2004–2016: A multilevel analysis

et al. 2021

View full text Add to dashboard Cite

show abstract

Descriptive epidemiology of gastric adenocarcinoma in the State of Texas by ethnicity: Hispanic versus White non-Hispanic

Cited by 12 publications

References 41 publications

The Descriptive Epidemiology of Gastric Cancer in Central America and Comparison with United States Hispanic Populations

The Descriptive Epidemiology of Gastric Cancer in Central America and Comparison with United States Hispanic Populations

Evaluation of treatment and outcomes for Hispanic patients with gastric cancer at Commission on Cancer‐accredited centers in the United States

Gastric adenocarcinoma burden and late‐stage diagnosis in Latino and non‐Latino populations in the United States and Texas, during 2004–2016: A multilevel analysis

Contact Info

Product

Resources

About